These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 6163740)
21. Effect of progesterone pretreatment on guinea pig gallbladder motility in vitro. Ryan JP; Pellecchia D Gastroenterology; 1982 Jul; 83(1 Pt 1):81-3. PubMed ID: 6281127 [TBL] [Abstract][Full Text] [Related]
22. Neuropeptides of the cholecystokinin group: effects and mechanisms of action on the gastro-intestinal and gall bladder motility. Milenov K; Kalfin R; Todorov S; Raichev P Acta Physiol Pharmacol Bulg; 1998; 23(3-4):85-91. PubMed ID: 10672334 [TBL] [Abstract][Full Text] [Related]
23. Stimulation of growth of azaserine-induced putative preneoplastic lesions in rat pancreas is mediated specifically by way of cholecystokinin-A receptors. Povoski SP; Zhou W; Longnecker DS; Roebuck BD; Bell RH Cancer Res; 1993 Sep; 53(17):3925-9. PubMed ID: 8358719 [TBL] [Abstract][Full Text] [Related]
24. CCK-58 is the only detectable endocrine form of cholecystokinin in rat. Reeve JR; Green GM; Chew P; Eysselein VE; Keire DA Am J Physiol Gastrointest Liver Physiol; 2003 Aug; 285(2):G255-65. PubMed ID: 12686511 [TBL] [Abstract][Full Text] [Related]
25. Development of CCK-tetrapeptide analogues as potent and selective CCK-A receptor agonists. Shiosaki K; Lin CW; Kopecka H; Craig R; Wagenaar FL; Bianchi B; Miller T; Witte D; Nadzan AM J Med Chem; 1990 Nov; 33(11):2950-2. PubMed ID: 1700123 [No Abstract] [Full Text] [Related]
26. [Structure-activity relationship of cystokinins: analogs exhibiting selective activity]. Martinez J; Rodriguez M; Lignon MF; Galas MC; Amblard M; Rolland M; Mendre C; Fulcrand P; Laur J; Bernad N J Pharm Belg; 1991; 46(1):9-16. PubMed ID: 2051303 [TBL] [Abstract][Full Text] [Related]
27. [Synthesis and biological activity of new cholecystokinin (CCK)-analogs with a special CCK-A receptor antagonistic effect]. Boomgaarden M; Henklein P; Sohr R; Morgenstern R; Martinez J; Ott T Pharmazie; 1990 May; 45(5):377-8. PubMed ID: 2395905 [No Abstract] [Full Text] [Related]
28. Syntheses and biological activities of methoxinine-analogues of the C-terminal octapeptide of cholecystokinin-pancreozymin. Gillessen D; Trzeciak A; Müller RK; Studer RO Int J Pept Protein Res; 1979 Feb; 13(2):130-6. PubMed ID: 429089 [TBL] [Abstract][Full Text] [Related]
29. Protease-catalyzed peptide bond formation: application to synthesis of the COOH-terminal octapeptide of cholecystokinin. Kullmann W Proc Natl Acad Sci U S A; 1982 May; 79(9):2840-4. PubMed ID: 6283547 [TBL] [Abstract][Full Text] [Related]
30. Double bond isosteres of the peptide bond: synthesis and biological activity of cholecystokinin (CCK) C-terminal hexapeptide analogs. Shue YK; Tufano MD; Carrera GM; Kopecka H; Kuyper SL; Holladay MW; Lin CW; Witte DG; Miller TR; Stashko M Bioorg Med Chem; 1993 Sep; 1(3):161-71. PubMed ID: 8081848 [TBL] [Abstract][Full Text] [Related]
31. Synthesis and stereochemical structure-activity relationships of 1,3-dioxoperhydropyrido[1,2-c]pyrimidine derivatives: potent and selective cholecystokinin-A receptor antagonists. Martín-Martínez M; Bartolomé-Nebreda JM; Gómez-Monterrey I; González-Muñiz R; García-López MT; Ballaz S; Barber A; Fortuño A; Del Río J; Herranz R J Med Chem; 1997 Oct; 40(21):3402-7. PubMed ID: 9341915 [TBL] [Abstract][Full Text] [Related]
32. Absence of effect of somatostatin on the guinea pig gallbladder. Poitras P; Yamada T; Walsh JH Can J Physiol Pharmacol; 1980 Feb; 58(2):179-82. PubMed ID: 6103746 [TBL] [Abstract][Full Text] [Related]
33. Structure-activity relationships of gastrointestinal hormones: motilin, GIP, and [27-TYR]CCK-PZ. Yajima H; Kai Y; Ogawa H; Kubota M; Mori Y Gastroenterology; 1977 Apr; 72(4 Pt.2):793-6. PubMed ID: 190081 [TBL] [Abstract][Full Text] [Related]
34. Novel CCK analogues and bombesin: a detailed analysis between phosphoinositide breakdown and high-dose inhibition of pancreatic enzyme secretion in three rodent species. Bianchi BR; Miller TR; Witte DG; Lin CW J Pharmacol Exp Ther; 1994 Feb; 268(2):996-1002. PubMed ID: 7509394 [TBL] [Abstract][Full Text] [Related]
35. Solid-phase synthesis of porcine cholecystokinin-33 in a new resin via FMOC-strategy. Penke B; Nyerges L Pept Res; 1991; 4(5):289-95. PubMed ID: 1802240 [TBL] [Abstract][Full Text] [Related]
36. Effect of desamino-cholecystokinin-octapeptide (CCK-7) on the intraluminal pressure and myoelectrical activity of the gall-bladder, stomach, and small intestine in conscious dogs. Milenov E; Nieber K; Niedrich H; Oehme P; Vogt WE Br J Pharmacol; 1983 Dec; 80(4):681-9. PubMed ID: 6100845 [TBL] [Abstract][Full Text] [Related]
37. Motor interaction between cimetidine and cholecystokinin-related peptides in the gall bladder. Stasiewicz J; Szałaj W; Gabryelewicz A Pol J Pharmacol Pharm; 1980; 32(5):643-6. PubMed ID: 7267456 [TBL] [Abstract][Full Text] [Related]
38. Calcitonin gene-related peptide as modulator of cholecystokinin-induced contraction of guinea pig gall bladder strips in vitro. Kline LW; Pang PK Ann N Y Acad Sci; 1992 Jun; 657():541-2. PubMed ID: 1637119 [No Abstract] [Full Text] [Related]
39. The effect of intravenously administered sincalide on the human gallbladder during oral cholecystography. Katevuo K; Kanto J Ann Clin Res; 1982 Aug; 14(4):157-9. PubMed ID: 6301354 [TBL] [Abstract][Full Text] [Related]
40. Structure-activity studies of C- and N-terminal fragments of cholecystokinin 26-33 in guinea pig isolated tissues. Gaudreau P; St-Pierre S; Pert CB; Quirion R Neuropeptides; 1987 Jul; 10(1):9-18. PubMed ID: 3670570 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]